comparemela.com

Latest Breaking News On - Charles nicolette - Page 1 : comparemela.com

CoImmune Announces Novel Engineered CAR T Cells Improve Anti-Tumor Activity and Reverse Immunosuppression in Preclinical Models

/PRNewswire/ CoImmune, Inc., a clinical stage immuno-oncology company working to redefine cancer treatment using best-in-class cellular immunotherapies,.

Lori-harrelson
Adam-daley
Charles-nicolette
David-scheinberg
Sloan-kettering-institute-center
Berry-company-public-relations
Coimmune-inc
Prnewswire-coimmune-inc
Memorial-sloan-kettering-cancer-center
Sloan-kettering-institute
Experimental-therapeutics
Chief-executive-officer

STAT's guide to the next generation of CAR-T therapies

Scientists are working on the next generation of CAR-T therapies from armored CARs to controllable CARs to combat cancer.

Stanford
California
United-states
San-diego
Shivani-srivastava
Marcela-maus
Wilson-wong
Charles-nicolette
Yvonne-chen
Peter-yingxiao-wang
University-of-california
Cancer-center

CAR-T SEAKER Cells Activate Small Molecule Drugs at Tumor Site

CAR-T cells, engineered to act as cancer drug "micropharmacies," could address challenges with eliminating tumor masses and toxicity.

Charles-nicolette
David-scheinberg
Nature-chemical-biology
Memorial-sloan-kettering-cancer-center
Sloan-kettering-institute
Synthetic-enzyme-armed
Derek-tan

Sloan Kettering Institute Researchers retool CAR T cells to serve as 'micropharmacies' for cancer drugs

Immunotherapies called chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient’s own immune cells to fight cancer

Davida-scheinberg
Charles-nicolette
National-institutes-of-health
Molecular-pharmacology-program
Chemical-biology-program
Memorial-sloan-kettering-cancer-center
Sloan-kettering-institute
Synthetic-enzyme-armed
Biology-program-chair-derek-tan
Nature-chemical
Experimental-therapeutics
National-institutes

Investegate |CoIMMUNE Announcements | CoIMMUNE: CoImmune Announces Positive Results from Phase 1/2 Clinical Trial of Allogeneic CAR-CIK Cells in Pediatric and Adult Patients with Acute Lymphoblastic Leukemia

Investegate announcements from CoIMMUNE, CoImmune Announces Positive Results from Phase 1/2 Clinical Trial of Allogeneic CAR-CIK Cells in Pediatric and Adult Patients with Acute Lymphoblastic Leukemia

Milano
Lombardia
Italy
Monza
United-states
Bicocca
Sicilia
American
Lori-harrelson
Adam-daley
Chiara-magnani
Charles-nicolette

vimarsana © 2020. All Rights Reserved.